Priority Date: 15.08.12 (US 201261683549P)

METHODS AND COMPOSITIONS FOR ENHANCING INTRANASAL DELIVERY OF THERAPEUTIC AGENTS

  • Application ID: EP13753052
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Transfer Office

Attorney

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1141.04
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) J A Kemp is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 15.08.2012 - Priority Date (US 201261683549P)
  • 20.02.2014 - Publication A1 (WO2014028694)
  • 24.06.2015 - Publication A1 (EP2884995)

IPC Classification